Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Medication management cabinet provides high-dose efficiency for nurses and caregivers in LTC
By
Aaron Dorman
Mar 15, 2024
Using an automatic medication dispensing cabinet at long-term care facilities cut down medication retrieval time by more than 50%, according to the results of a new study.
Risk profile IDs COVID-19 patients who will benefit from baricitinib
Feb 26, 2024
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
Prescription opioids linked to increased risk for serious fall events
Feb 20, 2024
The findings seen among adults of all ages, especially those aged 85 years or older; the risk was highest in the first 28 days after initiation.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
High-concentration capsaicin patch can cut neuropathic pain intensity
Feb 07, 2024
During high-concentration capsaicin patch treatment, a significant decrease was seen in average daily morphine equivalent dose.
Senate hearing, OIG report target substance use disorders
By
Kimberly Marselas
Feb 01, 2024
Both reveal that older adults need more help than ever when it comes to getting the treatment they need to address such issues.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Denosumab linked to severe hypocalcemia in dialysis-dependent seniors
Jan 25, 2024
The risk increased for severe and very severe hypocalcemia for female dialysis-dependent Medicare patients aged 65 years or older.
Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.